MoneyWorks4Me

Ranbaxy Laboratories board to consider financial results

06 Jul 2012 Evaluate
Ranbaxy Laboratories has informed that a meeting of the board of directors of the company will be held on August 09, 2012, to consider and approve standalone and consolidated unaudited financial results for the second quarter and half year ended June 30, 2012 as reviewed by the statutory auditors of the company.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..